DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines
Cancer Commun (Lond)
.
2022 Aug;42(8):789-792.
doi: 10.1002/cac2.12326.
Epub 2022 Jun 18.
Authors
Zhifu Sun
1
,
Xuewei Wang
1
,
Pete Vedell
1
,
Jean-Pierre Kocher
1
Affiliation
1
Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 55905, USA.
PMID:
35716010
PMCID:
PMC9395315
DOI:
10.1002/cac2.12326
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cell Line, Tumor
DNA Methylation*
Demethylation
Epigenesis, Genetic
Humans
Neoplasms* / drug therapy
Neoplasms* / genetics
Grants and funding
P30 CA015083/CA/NCI NIH HHS/United States